Scholarlink

<p>Loss-of-function mutations in the <i>TP53</i> gene are the most frequent genetic events in human malignancies. However, the extent to which missense <i>TP53</i> mutations confer oncogenic gain-of-function (GOF) properties remains incompletely understood. Using genetically defined pancreatic cancer organoid models, we demonstrated that mutant p53 provides a selective growth advantage under acute environmental stress and drives molecular transition toward a basal-like state. Transcriptomic analyses showed that under stress conditions, organoids expressing mutant p53 adopted a basal-like gene expression program, a characteristic of a poor prognosis subtype of pancreatic cancer. Furthermore, the molecular subtype was reversed to the classical subtype once it returned to normal growth conditions, suggesting that transcriptional plasticity arises from acute changes in the tissue microenvironment. Given these context-dependent oncogenic properties, our findings suggest that targeting mutant p53 may be a promising therapeutic strategy for pancreatic cancer.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Mutant p53 regulates reversible subtype plasticity in pancreatic cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月1日

查看全文
  • June-Ha Shin,
  • Hwa-Ryeon Kim,
  • Jae-Seok Roe

摘要

Loss-of-function mutations in the TP53 gene are the most frequent genetic events in human malignancies. However, the extent to which missense TP53 mutations confer oncogenic gain-of-function (GOF) properties remains incompletely understood. Using genetically defined pancreatic cancer organoid models, we demonstrated that mutant p53 provides a selective growth advantage under acute environmental stress and drives molecular transition toward a basal-like state. Transcriptomic analyses showed that under stress conditions, organoids expressing mutant p53 adopted a basal-like gene expression program, a characteristic of a poor prognosis subtype of pancreatic cancer. Furthermore, the molecular subtype was reversed to the classical subtype once it returned to normal growth conditions, suggesting that transcriptional plasticity arises from acute changes in the tissue microenvironment. Given these context-dependent oncogenic properties, our findings suggest that targeting mutant p53 may be a promising therapeutic strategy for pancreatic cancer.